Anna Tancin Lambert, Barbara Ratajczak-Tretel, Riadh Al-Ani, Kathrine Arntzen, Grete Kristin Bakkejord, Hanna Marie Otterholt Bekkeseth, Vigdis Bjerkeli, Guttorm Eldøen, Anne Kristine Gulsvik, Bente Halvorsen, Gudrun Anette Høie, Hege Ihle-Hansen, Håkon Ihle-Hansen, Susanne Ingebrigtsen, Henriette Johansen, Christine Kremer, Siv Bohne Krogseth, Christina Kruuse, Martin Kurz, Ingvild Nakstad, Vojtech Novotny, Halvor Naess, Rehman Qazi, Mehdi Kallaj Rezai, Dag Marius Rørholt, Linn Hofsøy Steffensen, Jesper Sømark, Håkon Tobro, Thomas Clement Truelsen, Lejla Wassvik, Karen Lehrmann AEgidius, Maiju Pesonen, Mirko de Melis, Dan Atar, Anne Hege Aamodt
BACKGROUND AND PURPOSE: There are currently no biomarkers to select cryptogenic stroke (CS) patients for monitoring with insertable cardiac monitors (ICMs), the most effective tool for diagnosing atrial fibrillation (AF) in CS. The purpose of this study was to assess clinically available biomarkers as predictors of AF. METHODS: Eligible CS and cryptogenic transient ischaemic attack patients underwent 12-month monitoring with ICMs, clinical follow-up and biomarker sampling...
May 2023: European Journal of Neurology